Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up
Pfizer
Thomas Powles; Se Hoon Park; Claudia Caserta; Begoña P Valderrama; Howard Gurney; Anders Ullén; Yohann Loriot; Srikala S Sridhar; Cora N Sternberg; Joaquim Bellmunt; Jeanny B Aragon-Ching; Jing Wang; Bo Huang; Robert J Laliberte; Alessandra di Pietro; Petros Grivas